Table 1

RV integration site distribution in human CD34+ HSCs

Intergenic, %Intragenic, %Perigenic, %Total hitsWithin 10 kb from TSS, %Total vector/gene interactions*
CD34+ cells       
    RV vectors 16.7 55.0 28.3 1030 29.3 1517 
    LV vectors 17.4 71.7 10.9 849 16.1 1241 
    Control sequences 46.2 38.6 15.2 798 9.1 902 
    RV hot spots 16.0 56.6 27.4 219 22.2 302 
    LV hot spots 8.6 81.4 10.0 70 13.2 2114 
    Control hot spots 36.4 59.1 4.5 22 13.0 23 
HeLa cells       
    RV vectors 26.4 48.1 25.5 869 26.1 1219 
    RV hot spots 16.5 53.2 30.3 109 27.3 165 
Intergenic, %Intragenic, %Perigenic, %Total hitsWithin 10 kb from TSS, %Total vector/gene interactions*
CD34+ cells       
    RV vectors 16.7 55.0 28.3 1030 29.3 1517 
    LV vectors 17.4 71.7 10.9 849 16.1 1241 
    Control sequences 46.2 38.6 15.2 798 9.1 902 
    RV hot spots 16.0 56.6 27.4 219 22.2 302 
    LV hot spots 8.6 81.4 10.0 70 13.2 2114 
    Control hot spots 36.4 59.1 4.5 22 13.0 23 
HeLa cells       
    RV vectors 26.4 48.1 25.5 869 26.1 1219 
    RV hot spots 16.5 53.2 30.3 109 27.3 165 

Distribution of RV and LV integration sites unambiguously mapped in unselected CB- and BM-derived CD34+ HSCs, and RV integrations in HeLa cells from a previously published collection.27 . Integrations (total hits) were distributed as inside (intragenic), outside (intergenic), or at a distance of less than 30 kb upstream or dowstream (perigenic) from known genes (UCSC annotation). Insertions at a distance of ±10 kb from transcription start sites (TSSs) are indicated as percentage of the total vector/gene interactions. Control sequences were obtained from a randomly cloned library of Pst1/MseI-restricted, LM-PCR–amplified human CD34+ cell DNA.

*

Total number of genes within 30 kb from individual hits + intergenic hits.

Close Modal

or Create an Account

Close Modal
Close Modal